Duopharma Biotech Berhad, the distributor of the Sinopharm vaccine, was one of the winners of the pandemic. But with a price cap set by the government, how will that impact the company? Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd answers those questions and their strategy for growth.

Can ASEAN’s Digital Needs Push EdgePoint Past Key Pressures?
23:32

Pharmaniaga Post-PN17 Betting Big on Biopharma
23:56

Khairy Jamaluddin: Back in the Running
34:25